Merck & Co Inc

US

MRK

Health Care

126.94 ₽

Current price

Sell
126.94 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    1031 / 1328

  • Position in country

    11246 / 14179

  • Return on Assets, %

    0.3

    -2.7

  • Net income margin, %

    -8.4

    2.8

  • EBITDA margin, %

    1.2

    10.8

  • Debt to Equity, %

    93.2

    19.2

  • Intangible assets and goodwill, %

    36.7

    3.6

  • Revenue CAGR 3Y, %

    13.1

    8.5

  • Total Equity change 1Y, %

    -18.3

    0

  • Revenue Y, % chg

    1.4

    0.5

  • P/E

    964.1

    22.7

  • P/BV

    8.4

    1.5

  • P/S

    5.2

    2.3

  • EV/S

    5.7

    2.4

  • EV/EBITDA

    34.5

    7.4

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    9.7

    51.3

  • Forward P/E

    14.1

    15.6

  • Dividend Yield, %

    2.4

    1.7

  • Forward Dividend Yield, %

    2.6

    0.2

  • Expected dividend per share

    3.3

    0

  • Payout Ratio, %

    2068.7

    30.3

  • Dividend Ex Date

    2024-03-14

Get an analytical review of this company

Competitors

Ranks

  • Royalty Pharma PLC

    00%

  • Zoetis Inc

    00%

  • Eli Lilly and Co

    00%

  • Bristol-Myers Squibb Co

    00%

  • Elanco Animal Health Inc

    00%

  • Johnson & Johnson

    00%

  • Viatris Inc

    00%

  • Merck & Co Inc

    00%

  • Pfizer Inc

    00%

  • Catalent Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    318454.6

  • Ticker

    MRK.N

  • ISIN

    US58933Y1055

  • IPO date

    1941-01-01

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-26

  • Date fact. publication of reports

    2023-12-31

Company Description

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: